Clinical Trial Update: A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Update on a Phase 2 study of tislelizumab in combination with investigational agents for non-small cell lung cancer; the trial is currently active but not recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: BeiGene | Conditions: Non-small Cell Lung Cancer, Metastatic Non-small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING